Lijuan Zou Selected Research

elemene

12/2020	β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway.
1/2020	β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways.
1/2019	β-elemene inhibits radiation and hypoxia-induced macrophages infiltration via Prx-1/NF-κB/HIF-1α signaling pathway.
1/2017	β-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer.
8/2015	The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.
3/2015	Downregulation of peroxiredoxin-1 by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenografts.
10/2014	Down regulation of mammalian target of rapamycin decreases HIF-1α and survivin expression in anoxic lung adenocarcinoma A549 cell to elemene and/or irradiation.
1/2013	The effects of β-elemene on the expression of mTOR, HIF-1A, survivin in lung adenocarcinoma A549 cell.
2/2012	Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft.
2/2011	ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijuan Zou Research Topics

Disease

23	Neoplasms (Cancer) 08/2021 - 02/2012
7	Adenocarcinoma of Lung 01/2020 - 02/2012
7	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2011
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2021 - 08/2018
5	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 11/2011
4	Hypoxia (Hypoxemia) 01/2019 - 02/2012
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2018
1	Endometrial Neoplasms (Endometrial Cancer) 03/2022
1	Type 2 Diabetes Mellitus (MODY) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021
1	Endometrioid Carcinoma 07/2021
1	Disease Progression 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Anaplastic Thyroid Carcinoma 10/2019
1	Carcinogenesis 10/2019
1	Infections 10/2019
1	Melanoma (Melanoma, Malignant) 02/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Medulloblastoma 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Stomach Neoplasms (Stomach Cancer) 04/2016
1	Lung Injury 01/2016
1	Lymphatic Metastasis 02/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2015
1	Glioma (Gliomas) 03/2014
1	Renovascular Hypertension (Goldblatt Syndrome) 12/2011

Drug/Important Bio-Agent (IBA)

10	elemeneIBA 12/2020 - 02/2011
8	Pharmaceutical PreparationsIBA 08/2021 - 02/2011
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2012
4	Small Interfering RNA (siRNA)IBA 01/2018 - 10/2014
3	SurvivinIBA 10/2014 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2019
2	Epirubicin (Ellence)FDA LinkGeneric 01/2021 - 01/2021
2	MelatoninIBA 01/2021 - 02/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2019 - 01/2019
1	Long Noncoding RNAIBA 08/2021
1	baicaleinIBA 07/2021
1	Sodium Glutamate (Accent)IBA 01/2021
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	NF-kappa B (NF-kB)IBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Cell-Free Nucleic AcidsIBA 11/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019
1	Serine (L-Serine)FDA Link 10/2019
1	Tyrosine (L-Tyrosine)FDA Link 10/2019
1	Threonine (L-Threonine)FDA Link 10/2019
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2019
1	Epithelial Cell Adhesion MoleculeIBA 02/2019
1	LuciferasesIBA 02/2019
1	VemurafenibIBA 02/2019
1	Proto-Oncogene Proteins B-rafIBA 02/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	CholesterolIBA 01/2019
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2019
1	Filipin (Filipin III)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	VimentinIBA 08/2018
1	Ethidium (Ethidium Bromide)IBA 08/2018
1	Acridine OrangeIBA 08/2018
1	osthol (osthole)IBA 08/2018
1	BromidesIBA 08/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Differentiation AntigensIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	NVP-BKM120IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Cytochromes c (Cytochrome c)IBA 01/2018
1	CateninsIBA 01/2017
1	CREB-Binding ProteinIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	BufanolidesIBA 04/2016
1	ProstaglandinsIBA 01/2016
1	Messenger RNA (mRNA)IBA 03/2015
1	squamous cell carcinoma-related antigenIBA 02/2015
1	Hemoglobins (Hemoglobin)IBA 02/2015
1	TOR Serine-Threonine KinasesIBA 10/2014
1	SesquiterpenesIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	Capsules (Microcapsules)IBA 12/2011
1	TiangouIBA 12/2011
1	Multidrug Resistance-Associated ProteinsIBA 11/2011

Therapy/Procedure

7	Therapeutics 12/2021 - 02/2011
5	Radiotherapy 07/2021 - 01/2013
4	Drug Therapy (Chemotherapy) 01/2021 - 11/2011
2	Adjuvant Radiotherapy 03/2022 - 07/2021
2	Chemoradiotherapy 11/2019 - 02/2015
1	Qigong (Qi Gong) 12/2021
1	Brachytherapy 07/2021
1	Lab-On-A-Chip Devices 01/2018
1	Aftercare (After-Treatment) 02/2015